Monoamine oxidase B inhibitors, commonly known as MAO-B inhibitors, are a class of medications used primarily to treat Parkinson's disease. They work by inhibiting the activity of the enzyme monoamine oxidase B, which breaks down dopamine in the brain. By preventing this breakdown, MAO-B inhibitors help to increase the levels of dopamine, thereby alleviating some of the symptoms of Parkinson's disease.
